does glp 1 interact with lexapro Ozempic and Lexapro: What Patients Should Know About This Combination – PlexusDx Tirzepatide and Antidepressants: Safe to

Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study

On wellness podcasts, guests have described this effect as one of the hidden benefits that makes long-term lifestyle change easier

Johnen H, Lin S, Kuffner T, Brown DA, Tsai VWW, Bauskin AR, et al

Efpeglenatide Efpeglenatide is a novel, long-acting GLP-1 receptor agonist developed by Hanmi Pharmaceuticals (South Korea) utilizing the proprietary LAPSCOVERY (Long-Acting Protein/Peptide Discovery) technology platform

patients now stay on Wegovy, Zepbound after a year

However, they should not be used with DPP-4 inhibitors (such as sitagliptin), and insulin or sulphonylurea doses may need adjustment to prevent hypoglycaemia